Is there a correlation between vaginal chlamydia infection and cervical smear abnormalities? A community-based study in the Al-Ain district, United Arab Emirates

Journal of Obstetrics and Gynaecology Research

Volumn 32, Issue 1, 2006, Pages 63-67

  Ghazal Aswad, Saad ^a   Badrinath, Padmanabhan ^a,c   Osman, Nawal Ahmed ^a   Abdul Khalik, Samar ^b   Raasclou, Tove ^b  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b TAWAM HOSPITAL   (United Arab Emirates)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Cervical smear; Chlamydia; United Arab Emirates

Indexed keywords

ADOLESCENT; ADULT; AGED; ATYPICAL SQUAMOUS CELL OF UNDETERMINED SIGNIFICANCE; CHI SQUARE TEST; CHLAMYDIASIS; COMMUNITY; CORRELATION ANALYSIS; CYTOPATHOLOGY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; HEALTH SURVEY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; PAPANICOLAOU TEST; PREVALENCE; REVIEW; SCREENING; UNITED ARAB EMIRATES; UTERINE CERVIX CYTOLOGY; VAGINITIS;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; STATISTICS; UNITED ARAB EMIRATES; UTERINE CERVICAL DYSPLASIA; VAGINAL DISEASES;

EID: 33645227842     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2006.00352.x     Document Type: Review

References (22)

1. Ministry of Health, United Arab Emirates. The four leading causes of death, UAE 1989-1998. [Cited 5 May, 2005.] Available from URL: http://www.uae.gov.ae/moh/statfour.htm.
2. Sigurdsson K. Effect of organized screening on the risk of cervical cancer. Evaluation of screening activity in Iceland, 1964-91. Int J Cancer 1993 54 563 570.
3. Hakama M. Potential contribution of screening to cancer mortality reduction. Cancer Detect Prev 1993 17 513 520.
4. Department of Health. Chlamydia Trachomatis. Summary and Conclusions of CMO's Expert Advisory Group. London, UK Department of Health 1998.
5. Meijer CJ Calame JJ de Windt EJ et al. Prevalence of Chlamydia trachomatis infection in a population of asymptomatic women in a screening program for cervical cancer. Eur J Clin Microbiol Infect Dis 1989 8 127 130.
6. Hinkula M Pukkala E Kyyronen P et al. A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland. Br J Cancer 2004 90 1025 1029.
7. Takac I Gorisek B. Chlamydia trachomatis infection in women with and without cervical intraepithelial neoplasia. Int J STD AIDS 1999 10 331 333.
8. Ghazal-Aswad S Badrinath P Osman N Abdul-Khaliq S McIlvenny S Sidky I. Prevalence of Chlamydia trachomatis infection among women in a Middle Eastern Community. BMC Women's Health 2004 4 3.
9. Glaziou P. Sample size. Institut Pasteur. [Cited May 5, 2005.] Available from URL: http://www.pasteur-kh.org.
10. Solomon D Davey D Kurman R et al Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002 287 2114 2119.
11. Clearview Chlamydia MF. Inverness Medical 2005. [Cited November 10, 2005.] Available from URL: http://www.medical.unipath.co.uk/Chlamydia.cfm.
12. Statistical Package for Social Sciences (Computer program). Version 10.0 for Windows. Chicago, Illinois SPSS Inc 1999 [Cited May 5, 2005.] Available from URL: http://www.spss.com/spss10.
13. el-Shourbagy M Diab KM Abdalla MY et al. The usefulness of screening for chlamydia trachomatis infection with cervical mucus leukocyte estrase. J Obstet Gynaecol Res 1998 24 21 25.
14. Department of Health. Cervical Screening Programme, England 1999-2000. Department of Health, Bulletin 2000/30 November, 2000.
15. Terry RR. Management of patients with atypical squamous cells of undetermined significance (ASCUS) on Papanicolaou smears. J Am Osteopath Assoc 1996 96 465 468.
16. Luo L Wu SZ Chen J et al. Study on genital tract chlamydia trachomatis and gonococci infection in Han and minority (Naxi and Dai) women in China's two provinces. J Obstet Gynaecol Res 1999 25 221 230.
17. Schachter J Hill EC King EB et al. Chlamydia trachomatis and cervical neoplasia. JAMA 1982 248 2134 2138.
18. Koskela P Anttila T Bjorge T et al. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer 2000 85 35 39.
19. Wallin KL Wiklund F Luostarinen T et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. Int J Cancer 2002 101 371 374.
20. Molano M Weiderpass E Posso H et al. Prevalence and determinants of Chlamydia trachomatis infections in women from Bogota, Colombia. Sex Transm Infect 2003 79 474 478.
21. Jha PK Beral V Peto J et al. Antibodies to human papilloma virus and to other genital infectious agents and invasive cervical cancer risk. Lancet 1993 341 1116 1118.
22. Reesink-Peters N Ossewaarde JM Van Der Zee AG Quint WG Burger MP Adriaanse AH. No association of anti-Chlamydia trachomatis antibodies and severity of cervical neoplasia. Sex Transm Infect 2001 77 101 102.